← Evidence map

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

CD19xCD3 T cell engager shows therapeutic potential for refractory myasthenic syndromes.

Ali A HabibPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40818453